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Our laboratory has been interested over the past severalyears in producing a safe
andeffectivegonococcul vaccine. We have focused ourattention on the useofpurified
gonococcul components to avoid the inherent toxicity of lipooligosaccharides (LOS)'
present in vaccines using boiled organisms (1) or gonococcul membrane vesicles (2,
3) and to allow consistent production and effective standardization of the vaccine .
The use of protein I (PI), the gonoccal porin (4-6), as a vaccine candidate appears
to have several advantages .
PI, the major outer membrane protein of the gonococcus, is surface exposed (7),
and its structure has been defined (8, 9) . There are two main forms, PIA and PIB
(10-12), and these can be further subdivided into serovars (13-15) . PIA and PIB are
structurally similar (8, 9) except for distinct areas that account for their antigenic
and functional differences (7, 10, 14-21) . PIA is present on gonococci that are resis-
tant to complement-mediated killingby pooled normalhuman sera, andPIB is present
on gonococci that are sensitive to killing by normal human sera (16, 17, 19, 20, 22) .
PI is antigenically conserved as opposed to pili, which seem to have infinite vari-
ability (23-25) . Gonococcal protein III (PIII) is highly conserved ascompared with
PI but antibodies to PIII have been shown to block human serum killing of the or-
ganism (26-29) . Antibodies elicited by PI have been demonstrated to be bacteri-
cidal (18, 21, 30) and opsonic (18, 21, 31) . Additionally, PI does not undergo phase
variations as seen with protein II (32-34) .
Other investigators have used LPS-depleted membrane vesicles as a potential PI
gonorrheal vaccine (2, 3) . These vesicles were derived from whole organisms and
therefore, in addition to PI, they contain other constituents of the gonococcul outer
membrane that may be harmful or decrease the effectiveness of the anti-PI anti-
bodies, e.g., by eliciting anti-PIII-blocking antibodies . Arminjon et al. (2) immunized
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subjects who had a history of previous gonococcal infections with such a vaccine .
Many of the individuals' sera contained bactericidal and opsonic activity before in-
oculation, which decreased after immunization . Studies are being conducted presently
to determine ifthis was a result of the production of PIII antibodies evoked by these
vesicles because, as Rice et al . (26-28) have demonstrated, anti-PIII antibodies block
human serum bactericidal killing of gonococci (29) .
To optimize an effective antibody response to PI and reduce the potential produc-
tion of anti-PIII-blocking antibodies, we chromatographically purified PI and then
examined the immune response to this PI preparation combined with two different
adjuvants . We investigated the effect ofalum because its potentiation of the immune
response has been shown for many antigens and it is currently the only adjuvant
approved for human use. Liposomes were also studied because of their known adju-
vant effects (35-40) and because we had previously shown that PI maintained both
its structural conformation and function within these vesicles (6) . Moreover, other
investigators have used liposomes as carriers for several candidate vaccines as reviewed
by Alving and coworkers (40, 41) . Humans have tolerated liposome administration
when utilized as drug carriers for various antibacterial, antiviral, or antifungal agents
as recently reviewed by Popescu et al . (42) and Lopez-Berenstein andJuliano (43) .
Cancer chemotherapy drugs have also been administered utilizing liposomes as re-
cently reviewed by Weinstein (44) .
In this study different mixtures ofPI combined with alum, liposomes, or Freund's
adjuvant were prepared and injected into rabbits . The sera wereexamined for anti-pro-
tein I antibodies, and the specificity of these antibodies was analyzed, including the
ability of these antibodies to be bactericidal and/or opsonic.
Materials and Methods
Organisms
The organisms used were a nonpiliated, transparent, serum-sensitive gonococcal strain
originally isolated from a urogenital infection, Pgh 3-2 (kindly provided by Dr. Charles Brinton,
University of Pittsburgh, Pittsburgh, PA), and a nonpiliated, transparent, serum-resistant
gonococcal strain originally isolated from a disseminated infection, UUl (kindly provided
by Dr. Zell McGee, University of Utah, Salt Lake City, UT) . Unless otherwise mentioned
the isolates were used after 16-20 h of growth on gonococcal agar (45) in a 5% C02 incu-
bator maintained at 37°C .
PI Isolation
PI was isolated by methods previously described (46-48) . All purification steps were car-
ried out at room temperature unless stated otherwise . The bacteria were harvested by cen-
trifugation and slowly resuspended in an equal volume of 1.0 M sodium acetate, pH 4.0,
containing 1mM 2,3-dimercaptopropanol . To this suspension was added 6 vol of5% (wt/vol)
Zwittergent N-tetradecyl-NN-dimethyl-3-ammonia-propanesulfonate (Z 3,14) (Calbiochem-
Behring Corp ., LaJolla, CA) in 0.5 M CaC12, and this was stirred for 1 h . 2 vol of absolute
ethanol was added slowly to bring the concentration to20% (vol/vol) . The precipitate, which
contained most of the nucleic acids, was removed by centrifugation at 17,000 g for 15 min .
The concentration of ethanol in the supernate was increased to 80% (vol/vol) and the resul-
tant precipitate was recovered by centrifugation. This precipitate, which contained PI, was
resuspended in 50mM Tris-HCI, pH 8.0, 10mM EDTA, and 5% Z 3,14 . This mixture was
stirred for 1 h and clarified by centrifugation at 12,000 g for 15 min . The soluble material
was applied to two columns (2.6 x 30 cm) linked in tandem, one packed withDEAE Sepharose
CL-6B (Pharmacia Fine Chemicals, Piscataway, NJ) and the second packed with CM Sepharose
CL-6B (Pharmacia Fine Chemicals), both equilibrated with 50mM Tris HCl, pH 8.0, withWETZLER ET AL.
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10 mM EDTA and 0.05 % Z 3,14. The eluate was monitored by 280 nm absorbance and SDS-
PAGE. After sample application, the columns were washed with equilibration buffer until
the 280 nm absorbance reached baseline. The majority of PI flowed through both columns.
The flow through was saved and the PI was precipitated by the addition of absolute ethanol
to a concentration of 80% (vol/vol). The precipitate was retrieved by centrifugation at 12,000
g for 15 min. This precipitate was dissolved in 10 ml of 50 mM Tris-HCI, pH 8.0, with 10
mM EDTA and 5% Z 3,14 and was applied to a column (2.6 x 170 cm) of Sephacryl S-300
(Pharmacia Fine Chemicals). The elution buffer was 100 mM Tris-HCI, 200 mM NaCl, 10
mM EDTA, 0.05% Z 3,14, pH 8.0, and the flow rate was 10 ml/h. Fractions of 7.5 ml were
monitored for absorbance at 280 nm, collected, and analyzed by SDS-PAGE. The fractions
that contained PI were pooled and utilized in the immunizing preparations.
PI-Aduaant Preparations
Alum PI.
￿
The purified PI described above was filtered through a 0.22-um filter (Milli-
pore Continental Water Systems, Bedford, MA) with no significant loss ofthe protein as mea-
sured by Coomassie blue assay (49). All further steps were done under aseptic conditions.
To determine the maximum amount ofPI that could be bound to alum, aluminum hydroxide
(Alu-Gel-S; Serva Feinbiochemica, Heidelberg, FRG) was washed with 0.9% NaCl and ali-
quoted. PI was added in increasing amounts to a series of identical alum aliquots, mixed,
and rotated for 1 h at room temperature. These samples were centrifuged and the supernates
were removed carefully. The amount of PI that remained unabsorbed was determined by
the Coomassie blue assay (49). Up to 1.5 mg of PI could bind to 10 mg of alum. Various
amounts of PIB were bound to 10 mg of alum to obtain different PI/alum ratios: 1 :10 (1,000
jig PI), 1 :40 (250 wg PI), 1 :100 (100 ug PI). For the PIA experiments 200 jig PI was bound
to 10 mg of Alum. After repeated 0.9% NaCl washes, the 10 mg alum PI mixtures were
resuspended in I ml of 0.9% NaCl.
LiposomePI.
￿
Liposomes were prepared by avariation ofa described method (50) as follows.
(a) The detergent in which the PI was dissolved was changed to D-octyl glucoside (OG) (Al-
drich Chemical Co., Milwaukee, WI) by precipitating the PI by the addition of ethanol, 50
mM sodium acetate, to a concentration of66.7 % (vol/vol), centrifuging this mixture at 10,000
g for 10 min, and resuspending the precipitate in 10% (wt/vol) OG in 10 mM Hepes; (b)
the liposomal lipids, synthetic phosphatidyl ethanolamine (PE), and phosphatidyl choline
(PC) (Avanti Polar Lipids, Inc., Birmingham, AL) dissolved in chloroform(20 mg/ml), were
mixed in a ratio of 3:1 (100 mg PE/33 mg PC) for PIB and 4:1 (16 mg PE/4 mg PC) for
PIA and dried in a thin layer on the inside ofan acid-cleaned test tube by rotary evaporation;
(c) 3 ml of purified PIB, 1 mg/ml, or I ml of purified PIA, 4 mg/ml, in the OG was added
to the dried POPE mixture, which dissolved the lipids and gave a clear solution; (d) the
solution was dialyzed extensively against PBS, pH 7.2, to remove the OG and induce lipo-
some formation; and (e) the dialyzed solution was sonicated (Branson Sonic Water Bath, Plain-
view, NY) to form small unilammellar vesicles. EM confirmed the production of small unilam-
mellar vesicles (kindly done by Drs. D. Dorset and A. Mikalski, Buffalo, NY). To determine
if the PIB is oriented in the liposomes in a similar way to that observed in the intact outer
membranes, the chymotryptic-generated peptides ofPIB in liposomes, purified PIB in deter-
gent, and PIB associated with intact bacterium were compared. Samples of each were pre-
pared such that each had similar quantities of PIB (1 mg/ml). Chymotrypsin (Boehringer
Mannheim Biochemicals, Indianapolis, IN) was added to each sample in a PIB to enzyme
ratio of 25 :1 (mg/mg) and incubated for 30 min at 37°C. The samples were then analyzed
by SDS-PAGE. Liposomes containing PIA were analyzed in a similar way, using proteinase
K (Sigma Chemical Co., St. Louis, MO) as the proteolytic enzyme.
Freund's Adjuvant PI.
￿
The primary injections were made by emulsifying 0.2-0.5 mg of
PI with 1.0 ml of CFA (Difco Laboratories Inc., Detroit, MI). For all subsequent injections,
the emulsion was made using IFA.
Immunization Protocol
New Zealand white rabbits (Marland, Hewitt, NJ) weighing 2.5-3 .0 kg were used in all
experiments. Rabbits were immunized subcutaneously with the various PI preparations. For
timing and amounts see Table I.1886
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Whole Organism Antisera Production
10 8CFU of Pgh 3-2 orUUI mixedwith CFA (Difco Laboratories, Inc.) was injected into
a rabbit, and 3 wk later the rabbit was boosted with the same amount of organisms in IFA .
ELISA Determinations
Microtiter plates (Dynatech Laboratories, Inc., Alexandria, VA)were sensitized by adding
0.1 ml per well of PI (2 ug/ml), in 0 .05 M sodium carbonate buffer, pH 9.8, with 0.02%
azide . The plates were incubated overnight at room temperature. The plates were washed
five times with 0.9% NaCl, 0.05% Brij 35, 10 mM sodium acetate, pH 7 .0, 0.02% azide .
Therabbit sera, starting at adilution of 1 :1,000 in 10mM Tris, pH 8.2, 0.15M NaCl, 0.05%
Brij 35, 0.0217o azide (incubating buffer), were incubatedon the plate for 4hat room temper-
ature . The plates were again washed as before and the appropriate secondary antibody, ei-
ther alkaline phosphatase-conjugated goat anti-rabbit (Tago Inc., Burlingame, CA) or goat
anti-mouse (Tago Inc.), were diluted in the incubating buffer, added to the plates, and in-
cubated for 2 h at room temperature. The plates were washed as before andp-nitrophenyl
phosphate (Sigma Phosphatase Substrate 104 ; Sigma Chemical Co.) (1 mg/ml) in 0.1 M
diethanolamine, 1 mm MgC12, 0.1 mM ZnC12 , 0.02% azide, pH 9.8, was added . The plates
were incubated at 37°C for 1 h andtheabsorbance at 405 nm wasdetermined usingan Elida-
5spectrophotomer(Physics, NewYork, NY) . Control wells lacked either the primary and/or
secondaryantibody. To determine the amount of antibody raised to aknownsurface-exposed
area on PIB, asynthetic peptide containing the amino acid sequence ser-ile-pro-ser-leu-phe-
val-glu-lys-leu-gln-val-his-arg-leu-(cys) was used . This sequence is found in PIB at amino
acid residues 199-213 and starts at the chymotrypsin cleavage site in this molecule. The mi-
crotiter plates were sensitized as before with apeptide concentration of 0.5 ug/ml . The ELISA
values are reported as the dilutions that gave an absorbance of 1.0 at 405 nm aftera 1-h incu-
bation .
SDS-PAGE and Western Blot
The SDS-PAGE was a variation of Laemmli's method (51) as described previously (47) .
Electrophoretic transfer to nitrocellulose wasperformed according to the methods ofTowbin
et al . (52) and the Western blots were probed with phosphatase-conjugated reagents (53) .
Primaryand secondary antibodies were the same as those used in the ELISA assays described
above .
Absorption of Sera with Whole Organisms
Gonococciwere harvestedfrom agar plates withadacron swab and resuspended in a Pro-
teose Peptone No. 3 broth (Difco Laboratories, Inc.) with 0.9% NaCl . The turbidity was
measured on a spectrophotometer (Perkin-Elmer Corp., Maywood, IL) set at 600nm and
the cells were diluted to an absorbance of0.1 (-108 CFU/ml) . The suspended organisms were
aliquoted so that when collected by centrifugation and resuspended in diluted antisera, the
final concentration of organisms was -108/ml . The various sera were titrated in 0.9% NaCl
to a dilution that gave an ELISA valueof 1 .0 . The diluted sera were added to thecentrifuged
organisms, the organisms were resuspended, and the mixtures were incubated on ice for 30
min.Thebacteria were concentrated by centrifugation andthe serum was carefully removed .
After each absorption, a small volume from each aliquot of absorbed serum was removed
forELISAanalysis . Continuedabsorptions were done a total offive times . TheELISAvalues
of absorbed sera were compared with that of unabsorbed sera at the same dilution .
Microtiter Bactericidal Assay
A method similar to that described by Schneiderand Griffiss (54) was used to determine
the bactericidal activity of antisera. They were diluted 1 :40 and then serially diluted twofold
in microtiter plates (Microtest III; Becton Dickinson& Co ., Mountain View, CA). Organisms,
grown for 16-20 h on gonococcal agar were resuspended in gonococcal buffer (GB, 0.01M
potassium phosphate buffer, pH 7.2, containing NaCI 7.94 g/liter, KC10.37 g/liter, CaC1 2-2X
H2O 0.25 g/liter, MgCl2-6H20 0.06 g/liter, MgS04-7H2O 0.246 g/liter, BSA 0.01%) and
diluted to an OD of 0.1 at 600 nm (-108 CFU/ml). Reaction mixtures in each well consistedWETZLER ET AL.
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of 25 ul of heat-inactivated diluted sera, 10 gl hypogammaglobulinemic serum as a comple-
ment source (kindly provided by Dr. Robert Lahita, The Rockefeller University, New York,
NY), 25 gl of gonococci, and 40 ul of GB. The antiserum dilutions were done in duplicate
and control wellslacked added complement. The microtiter plates were incubated for 30 min
at 37°C. Then 100 pl ofgonococcalmedia (45) with low melting point agarose (FMC, Rock-
land, ME) cooled to 37°C was added to each well and the entire plate incubated in a 37°C,
5% COz incubator for 24 h. The bactericidal titer was considered to be the dilution in the
last well that had >95% killing.
Agglutination of Whole Organisms
Sera were diluted 1 :10 in GB and 0 .1 ml was added to 0.1 ml oflog phase whole organisms
diluted to an OD of 0.1 at 600 nm. Agglutination was graded by light microscopy on a scale
from 0 to 4+ .
Opsonophagocytosis Assay
To measure the opsonic effects ofthe sera, a variation of the procedure described by Ross
et al. (55) was used. Polymorphonuclear cells (PMN) were procured by collectingwhole blood
of normal human volunteers in a heparinized syringe. The bloodwas diluted 1 :1 with sterile
2% gelatin in 0.9% NaCl and was allowed to stand for 30 min at 37°C. The serum fraction
was removed and centrifuged at 3,000 g for 15 min. The residual RBC in the PMN-enriched
pellet were lysed by the addition of 0.85% NH4Cl, and the PMN were recovered by cen-
trifugation. PMN were washed twice in M199 (KC Biological, Inc., Lenexa, KS) and
resuspended at a concentration of 107 PMN/ml. Viability of the PMN was assessed by the
trypan blue exclusion assay. The gonococci were grown to exponential phase in Proteose Pep-
tone no. 3 (Difco Laboratories, Inc.) broth with defined supplements (Isovitalex, BBL Microbi-
ology Systems, Cockeysville, MD). The organisms were washed with GB and resuspended
to an OD of 0.1 at 600 nm (N10a CFU/ml) and diluted 10-fold. The volume of the reaction
mixture was 0.25 ml, whichconsisted of 10% undiluted antiserum, 10% undiluted C8-deficient
serum (kindly provided by Dr. Keith Joiner, NIH), 0.1 ml of the diluted organisms (ti 106
CFU), and 0.1 ml of the resuspended PMN (ti106). Each reaction mixture was put in a 12
x 75-mm snap cap plastic tube (Becton Dickinson Labware, Oxnard, CA) and rotated for
30 min at 37 °C. Samples at zero time and 30 min were taken and diluted appropriately to
measure survival. To test the opsonizing ability of mAb 9A1, an mAb to PIB, 25 Al of un-
diluted mAb was added to the reaction mixture instead ofimmune sera. The relative survival
was the ratioofCFU in the reaction mixtures containing C8D serum to the reaction mixtures
without C8D. Controls were mixtures without antiserum and/or C8D.
In some cases, the sera of rabbits displayed opsonic activity before immunization. Unfor-
tunately, this was determined only afterthese rabbits had been inoculated several times with
a PIA liposome preparation. To demonstrate that the opsonizing antibodies in these immune
sera were to PIA and not to other proteins (see Fig. 6), the PIA-reactive antibodies were
absorbed from one rabbit's serum, whose preimmune serum was not opsonic, on a PIA affinity
column until there was minimal PIA reactivity as demonstrated by Western blot (data not
shown). This absorbed serum was tested in the opsonophagocytic assay described aboveand
the relative survival ofUU1 utilizing PIA-absorbed serum was compared with the unabsorbed
immune serum and its preimmune counterpart.
Results
The purpose of this study was to evaluate several different immunization methods
to evoke functional antibodies to an integral membrane protein, i.e., the porins of
Nesseria gonorrhoeae. The functional aspects of these antibodies were defined as their
ability to (a) aggregate whole organisms; (b) be bactericidal; and (c) be opsonic for
gonococci. We used purified PI in FCA, bound PI to alum phosphate, and incorpo-
rated PI into liposomes. Of these three methods used to prepare PI for immuniza-1888
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tion, the last two have been approved for human use. The immunization protocol
of each of the preparations is shown in Table I .
To demonstrate that PI when inserted into liposomes has a similar orientation
as in theintact organisms, the PIA and PIB liposomeswere treated with proteinase
K or chymotrypsin, respectively . The resulting proteolytic fragments of both PIB
and PIA in liposomes migrated in SDS-PAGE like those generated when these en-
zymes were added to intact gonococci expressing these proteins (Figs . 1 and 2) (7) .
After three immunizations with PIB, the immune rabbit sera evoked by each of
the preparations gave comparable ELISA values with the exception ofFCA, which
elicited a 10-fold higher response in this assay (Table II) . Furthermore, the Western
Blot analysis indicated that the antibodies were reactive and specific for PIB (Fig .
3) . However, in comparing these immune sera for their ability to agglutinate intact
gonococci, they differed quite radically . Theimmune sera raised using the alum prepa-
rations agglutinated Pgh 3-2 very weakly (0-1+) and at lower titers . Whereas, the
antisera raised usingliposomes agglutinated Pgh 3-2 more avidly (2-3 +)andat higher
dilutions. This suggested to us that more of the antibodies in the immune sera pro-
duced by theliposomes were directed at surface-oriented epitopes on the gonococci .
Further evidence for this was seen in the assays measuring the bactericidal titers
(Table II) and opsonizing ability (Table III) of each of the antisera . As can be seen,
the immune antisera raised with theliposomes were betweentwo- andeightfoldmore
bactericidal than those raised with alum and were equivalent to the immune sera
elicited with Freund's adjuvant . The PI liposome immune sera also showed greater
opsonophagocytosis activity compared with the alum sera (Table III) .
Similar experiments were performed using purified PIA from strain UU1 . The
ELISA values of the immune sera raised to PIA using alum as an adjuvant were
comparable with those seen with the PIB (Table II) . But the titers of the antisera
from rabbits inoculated with PIA liposomeswere 5-10-fold lower in this assay . How-
ever, as with the PIB experiments, the PIA liposome antisera had two- to fivefold
higher bactericidal titers than the PIA alum antisera (Table II) despite their lower
ELISA values . The Western blots ofthe PIA antisera demonstrated their reactivity
to PIA(Fig . 4) but also showed reactivity with other gonococcal proteins, including
PIII . To demonstrate that it was the PIA antibodies that were opsonic, PIA-liposome
TABLE I
Immunization Protocol
Organism Adjuvant Amount PI Injections Interval Rabbits
mg wk
Pgh 3-2 Alum 1 .0 3 3 1
0.25 3 3 1
0.10 3 3 1
Liposome 0.10 3 1 1
0.20 3 1 1
Freund's 0.20 2 3 1
UU1 Alum 0.20 3 2 2
Liposome 0 .20 3 2 2
Freund's 0 .20 2 2 1WETZLER ET AL . 1889
FIGURE 1 .
￿
SDS-PAGE gel ofPIBliposomes . Lanes 1 and 4, molec-
ular weight standards; lane 2, PIB liposome, 25 gg PIB, untreated ;
lane 3, PIB liposome, 25 gg PIB, treated with 1 gg chymotrypsin at
37°C for 30 min (51) . Therewasalmost total degradation of PIB by
chymotrypsin demonstrating that a high percentage of the
chymotrypsin sensitive site of PIB exposed in vivo is also exposed in
the liposome construct (7). Molecular weight standards were human
transferrin (80,000), catalase (60,000),OVA (45,000), carbonic anhy-
drase (30,000), soy bean trypsin inhibitor (21,500), and cytochrome
c (12,500) .
immune serum, from a rabbit whose preimmune serum was not opsonic, was ab-
sorbed with purified PIA to remove the PIA antibodies . This serum was then reas-
sessed for its reactivity by Western blot analysis and the opsonophagocytie assay .
The Western blot demonstrated that most if not all the antibodies reactive to PIA
had been removed while the reactivity to the other gonococcal proteins remained
(data not shown) . The serum exhibited a marked loss of opsonic activity to UUl
gonococci(as compared with the antiserumbefore absorption), percent survival was
81% vs. 0 0 1o, respectively.
Both of these studies pointed to the fact that a higher percentage of the antibodies
elicited by PI incorporated into liposomes were directed at surface epitopes on the
gonococci . Two methods were used to confirm this hypothesis . A synthetic peptide
was made that extended from the know surface-exposed chymotrypsin cleavage site
consisting of amino acid residues 119-214 in the PIB sequence (56) . Using this pep-
tide inanELISAassay, the PIB liposome-generated antibodies were compared with
FIGURE 2 .
￿
SDS-PAGE ofPIAliposomes . Lanes 1 and
8, molecular weight standards as in Fig . 1 ; lane 2,
purified PIA, 25 gg, untreated ; lane 3, purified PIA,
25 gg, treated with proteinase K, i gg; lane 4, whole
UUl organism, untreated ; lane5, wholeUUIorganism
treated with proteinaseK; lane 6, PIA liposome, un-
treated ; lane 7, PIA liposome treated with proteinaseK .1890
￿
IMMUNOGENICITY OF GONOCOCCAL PROTEIN I
TABLE II
Serum Bactericidal Titers
the PIB alum-generated antibodies forreactivity to this area. As canbe seen in Fig.
5, the ELISA values for the liposome-elicited antibodies were much higher in this
assay (1:2,800 vs . 1:870) . The variousPIB antisera were serially absorbed with intact
Pgh 3-2; the antisera raised utilizing PIB liposomes retained <45% of their reac-
tivity, whilethe antisera raised utilizing PIB alum retained >75% of their reactivity
after absorption (Fig . 6) .
Discussion
The major outer membrane protein of the gonococcus is PI and comprises up
to 60% of the membrane protein of the organism (46) . PI has distinct advantages
FIGURE 3 .
￿
Pgh 3-2 Western Blot . Whole cell lysate ofstrain Pgh 3-2 was
transferred to the nitrocellulose . Lane 1, PIB liposome antiserum 0.100
mg PIB ; lane 2, PIB Alum antiserum, 1 :10 PIB to alum ratio, 10 mg
alum; lane 3, PIB Freund's antiserum; lane 4, PIB mAb 9A1 .
Antisera Bactericidal titer PI ELISA titer
Pgh 3-2
Preimmune 1 :320 0
Alum 1 :10 1 :640 1/250,000
Alum 1 :40 1 :640 1/240,000
Liposome (0.10 mg) 1 :1,280 1/220,000
Liposome (0.20 mg) 1 :5,120 1/180,000
Freund's 1 :5,120 1/2,400,000
Whole organism 1:20,480 1/230,000
UUl
Preimmune 1 :1,280 0
Alum no . 1 1 :1,280 1/200,000
Alum no . 2 1 :1,280 1/94,000
Liposome no . 1 1 :5,120 1/24,000
Liposome no . 2 1 :2,560 1/24,000
Freund's 1:1,280 1/270,000WETZLER ET AL .
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TABLE III
Pgh 3-2 (PIB) Opsonophagocytosis Survival
Antisera
￿
Relative survival
None
￿
0.65
Preimmune
￿
0.67
mAb 9A1
￿
0.05
Alum PI 1 :10
￿
1 .39
Alum PI 1 :40
￿
1 .04
Liposome PI (100 Wg PI)
￿
0.05
Liposome PI (200 Ag PI)
￿
0.04
Freund's PI
￿
0.07
Reaction mixture volume was 0.25 ml containing 10% undiluted sera, 10%
C8-deficient sera (kindly provided by Dr . KeithJoiner, NIH), 0 .1 ml ofPMNs
(10' PMNs/ml), and 0 .1 ml of diluted organisms (N107 CFU/nil) . Reaction mix-
tures were rotated for 30 min at 37°C and samples at zero time and 30 min were
taken and diluted appropriately. C8D did not contain bactericidal activity . Rela-
tive survival was a ratio percent survival ofCFU at 30 min inC8D plus tubes
vs . C8D minus tubes (55) .
as a gonococcal vaccine candidate. PI is antigenically conserved (14, 15) and por-
tions ofPI are exposed on the surface of theorganism (7). It has been demonstrated
byJoiner et al . (30)adn Virji et al . (18, 21) that antibodiesproduced to these surface-
exposed epitopes are bactericidal, opsonic, and can protect against gonococcal inva-
sion in an in vitro cell culture invasion assay. Furthermore, Sarafian et al . (31)demon-
strated Fab portions of PI mAb can block opsonic activity of human sera.
As stated, other investigators have used LPS-depleted membrane vesicles asapoten-
tial PI antigonococcal vaccine (2, 3) . These vesicles in addition to PI inevitably con-
FIGURE 4 .
￿
UUl Western blot. Whole cell lysate of strain UUl
was transferred to nitrocellulose . Lane I, PIA alum antisera,
1 :1,000 ; lane 2, PIA liposorne antisera 1 :1,000 ; lane 3, PIA
Freund's antisera, 1 :1,000 ; lane 4, PIII antisera; lane 5, India ink .
Arrowhead points to PIA band .1892
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tained some amount of PIII . A potential problem with the presence of PIII is the
induction of anti-PIII-blocking antibodies (26-29) . In the recent PI vaccine trial
by Arminjon et al . (2), multivalent gonoccocal vesicles, that contained PI and<10%
PIII, were injected into volunteers with ahistory of previous gonococcul infections .
Afterimmunization, the bactericidal and opsonic ability ofthe subjects' sera against
the gonococcus decreased instead of increasing as expected . The production of anti-
PIII-blocking antibodies is presumed to be the reason for this finding and further
studies are under way to confirm this hypothesis . To avoid these complications, we
wanted to use detergent-solubilized, chromatographically purified PI with minimal
PIII or LOS contamination .
Our next task was the presentation of the purified PI in a manner that would
elicit the most effective antibodies and, therefore, themethod of presenting this porin
in the most natural way was carefully considered . Studies of Escherichia coli outer
membrane porins (57, 58) demonstrate that they have a complex tertiary structure
with a large portionof the molecule in R sheet conformations . These monomerscom-
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PIB, which is surface exposed . (Abscissa) Recip-
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Whole cell absorptions. Sera were ab-
sorbed with whole Pgh 3-2 Mr. The sera were
diluted to a titer that gave an ODao5 of 1.0 by
ELISA . All absorptions and dilutions were done
in sterile 1% proteose peptone (Difco Laborato-
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each absorption for theELISAand sequential ab-
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bine in a trimeric quaterinary structure . PI, the porin of Neisseria gonorrhoeae, like-
wise forms trimers (46) and is structurally related to the E . coli porins (8) . Thus,
these porins can be envisioned as three cylinders that are bound together and span
the Gram-negative outermembrane . They have surface-exposed areas, regions that
represent the internal part of the cylinder, and portions that extended into the
periplasmic space . Antibodies elicited to otherthan surface-exposed epitopes would
thus be ineffective as we have demonstrated .
In this study, purified PI was presented absorbed to alum or incorporated into
liposomes. In each case ahumoral immune response was induced and high anti-PI
titers were detected in an ELISA assay . The antisera raised by both preparations
recognized PI on western blots, but the alum PI-induced sera did not agglutinate
intact gonococci and did not have an increase in bactericidal or opsonic activity.
Furthermore, these antibodies appeared to react poorly with surface-exposed epi-
topes . On the otherhand, PI inserted into liposomes in its native orientation asdemon-
strated by enzymatic studies (Figs . 1 and 2) raised antibodies that agglutinated in-
tact organisms and the sera had higher bactericidal and opsonic activity than the
preimmune sera and the PI alum sera . In addition the liposome antisera contained
a higher percentage of antibodies to exposed epitopes of PI as demonstrated by the
synthetic peptide ELISA assay and whole cell absorptions .
Other authors have shown that antigens associated with liposomes can be used
as immunogens andthat liposomes themselves canact as an adjuvant (35-38, 40-41)
and liposomes themselves are well tolerated by humans (41-44) . In this study, the
liposome-generated sera had greater functional reactivity towards the gonococcus
than the alum-generated sera . A possible reason that PI alum antisera produced
a smaller percentage of antibodies to exposed epitopes of PI is that alum is ionic
in nature. The alum may bind to the ionic, hydrophilic-exposed portions of the pro-
tein and mask these epitopes from the immune system . However, when PI is in-
serted in the liposome, the epitopes displayed in vivo are exposed on the liposome .
Antibodies produced utilizing this method are thus to the surface-exposed portions
of the protein . Jiskoot et al . (38) recently published a report where they raised an-
tisera to PI utilizing alum, detergents, andliposomes in variouscombinations . They
raised the greatest ELISA antibody titers to PI with alum, but they did not charac-
terize the functional activity of the antisera .
Even though the PI preparations used as immunogens contained minimal PIII
contamination (<1%), there was significant reactivity with PIII on the Western blot
(Figs . 3 and 4) . PIII is probably an excellent immunogen and can elicit a greater
antibody response per quantity ofprotein than the othermembrane proteins of the
gonococcus . This might be helpful to the gonococcus especially since it appears that
antibodies to PIII have blocking capabilities (26-29) and PIII is antigenically con-
served (48, 59, 60) . Despite the production of antibodies that recognized PIII on
the Western blots, we still observed increased bactericidal and opsonic activity.
In conclusion, PI is an obvious choice for a gonococcal vaccine candidate . The
adjuvant used to present PI as a vaccine can affect the epitopes of the protein that
are exposed to the host immune system and, therefore, the specific epitopes anti-
bodies raised will recognize. PI inserted into liposomes is apractical way to immunize
against a gonococcal antigenand raise antibodies to its surface with minimal blocking
antibody production . It is important to mention that we could not fully separate1894
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all PIII from PI and, therefore, some PIII antibodies were raised but these anti-
bodies did not appear to block bactericidal or opsonic activity.
Summary
A major goal of gonococcal research is the development of a gonorrheal vaccine .
A vaccine candidate is the major outer membrane protein (PI) of the gonococcus,
which has limited antigenic variability. Two main subtypes, PIA and PIB, and nine
main serotypes have been described . To avoid raising anti-protein III (PIII)-blocking
antibodies and limit potential lipooligosaccharide toxicity, PIwas chromatographi-
cally isolated withminimal PIII contamination (<I%) from Pgh 3-2 (PIB), a serum-
sensitive gonococcal strain andUU1 (PIA), a serum-resistant gonococcal strain . Alum
was used as an adjuvant and the antibodies raised in rabbits did not agglutinate
the organisms, were not opsonic, and bactericidal titers were not increased . To present
PI in a form mimicking its in vivo disposition, it was inserted into liposomes . The
resulting antisera did agglutinate the organism and contained opsonic and bacteri-
cidal activity greater than the preimmune sera or alum-generated sera. The PIB
liposome antisera also had higher ELISA titers to a synthetic peptide equivalent
to an exposed portion of PIB and a higher percentage of antibodies absorbed by
whole organisms than thePIBalum antisera . We speculate thatwhen PI is presented
in liposomes, the antibodies raised are mainly to surface-exposed epitopes of the
protein as opposed to when PI is presented absorbed to alum, where the antibodies
are produced mainly to buried epitopes .
We would like to thank Elizabeth Lytton, Kenneth Johnston, Rita Nash, Armando Castro,
and Tracy Guinta for assistance given during these investigations, andDr. Frank Robey, who
prepared the synthetic peptide used in this study.
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